LATENT AUTOIMMUNE DIABETES IN ADULTS

LATENT AUTOIMMUNE DIABETES IN ADULTS was reported 171 times

These drug classes are most commonly taken by patients reporting LATENT AUTOIMMUNE DIABETES IN ADULTS:

# Drug Count
0 Programmed Death Receptor-1 Blocking Antibody [EPC] 23
1 Insulin Analog [EPC] 22
2 Corticosteroid [EPC] 14
3 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 12
4 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 12
5 Polyene Antifungal [EPC] 11
6 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 10
7 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 9
8 Immunoglobulin G [EPC] 9
9 Benzodiazepine [EPC] 8
10 GLP-1 Receptor Agonist [EPC] 8
11 HMG-CoA Reductase Inhibitor [EPC] 7
12 Sulfonylurea [EPC] 7
13 Atypical Antipsychotic [EPC] 5
14 CTLA-4-directed Blocking Antibody [EPC] 5
15 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 5
16 Cytochrome P450 3A Inhibitor [EPC] 4
17 Dipeptidyl Peptidase 4 Inhibitor [EPC] 4
18 Interferon beta [EPC] 4
19 Nonsteroidal Anti-inflammatory Drug [EPC] 4
20 Protease Inhibitor [EPC] 4
21 Retinoid [EPC] 3
22 Azole Antifungal [EPC] 2
23 Estrogen [EPC] 2
24 Folate Analog Metabolic Inhibitor [EPC] 2
25 Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] 2
26 Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] 2
27 Integrin Receptor Antagonist [EPC] 2
28 Kinase Inhibitor [EPC] 2
29 Loop Diuretic [EPC] 2
30 Nonsteroidal Mineralocorticoid-Receptor Antagonist [EPC] 2
31 P2Y12 Platelet Inhibitor [EPC] 2
32 PCSK9 Inhibitor [EPC] 2
33 Peroxisome Proliferator Receptor alpha Agonist [EPC] 2
34 Peroxisome Proliferator Receptor gamma Agonist [EPC] 2
35 Platelet Aggregation Inhibitor [EPC] 2
36 Provitamin D2 Compound [EPC] 2
37 Serotonin-3 Receptor Antagonist [EPC] 2
38 Thiazolidinedione [EPC] 2
39 Vitamin C [EPC] 2
40 alpha-Glucosidase Inhibitor [EPC] 2
41 Androgen Receptor Inhibitor [EPC] 1
42 Angiotensin 2 Receptor Blocker [EPC] 1
43 Antimetabolite Immunosuppressant [EPC] 1
44 Aromatase Inhibitor [EPC] 1
45 CD20-directed Cytolytic Antibody [EPC] 1
46 CD52-directed Cytolytic Antibody [EPC] 1
47 Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] 1
48 Dietary Cholesterol Absorption Inhibitor [EPC] 1
49 Expectorant [EPC] 1
50 Glinide [EPC] 1
51 Hepatitis C Virus NS5A Inhibitor [EPC] 1
52 Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] 1
53 Insulin [EPC] 1
54 Interferon alpha [EPC] 1
55 Interleukin-17A Antagonist [EPC] 1
56 Interleukin-4 Receptor alpha Antagonist [EPC] 1
57 Microtubule Inhibitor [EPC] 1
58 Mood Stabilizer [EPC] 1
59 Nitrofuran Antibacterial [EPC] 1
60 Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] 1
61 Nucleoside Metabolic Inhibitor [EPC] 1
62 Platinum-based Drug [EPC] 1
63 Programmed Death Ligand-1 Blocker [EPC] 1
64 Purine Antimetabolite [EPC] 1
65 Tumor Necrosis Factor Blocker [EPC] 1
66 Vascular Endothelial Growth Factor Inhibitor [EPC] 1
67 Vitamin B12 [EPC] 1
68 Vitamin D [EPC] 1